From: A brief history of MECP2 duplication syndrome: 20-years of clinical understanding
Feature | Males n/N | Females n/N | Total n/N (%) | References |
---|---|---|---|---|
Respiratory infections | – | – | 367/498 (74%) | [1,2,3,4, 8,9,10, 12,13,14, 16,17,18,19,20,21,22, 24,25,26,27,28,29,30,31,32, 34,35,36,37,38, 40,41,42,43,44,45,46,47,48, 51,52,53, 55,56,57, 59,60,61,62,63,64, 66,67,68,69,70,71,72,73,74, 76,77,78, 81,82,83,84,85,86] |
Pharyngitis | 4/46 | 0/2 | 4/48 (8%) | |
Tonsilitis | 4/24 | 6/12 | 10/36 (28%) | |
Otitis media | – | – | 23/77 (30%) | |
Urinary tract infections | – | – | 14/56 (25%) | |
Sepsis | – | – | 11/88 (13%) | |
Lymphadenopathy | 2/8 | NR | 2/8 (25%) |